Clinical trial
Namenda to Prevent Post-Operative Delirium
NCT00303433 · University of Rochester, Other · Terminated
Key facts
| NCT number | NCT00303433 |
|---|---|
| Title | Namenda to Prevent Post-Operative Delirium |
| Official title | Namenda as Prevention for Post-Operative Delirium |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Delirium, Post-Operative States |
| Intervention type | Drug |
| Interventions | Namenda |
| Enrollment | 30 |
| Start date | Mar 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Mar 16, 2006 |
| Last update posted | Jun 3, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: